Figure 1. 3-(4, 5- dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay to evaluate cell viability; MTT assay result of HeLa cells treated with A1, Nanocurcumin; B1, Curcumin; and C1, Nanocarrier, and fibroblast cells treated with A2, Nanocurcumin; B2, curcumin; and C2, Nanocarrier. Error bar lines indicate the standard deviation level of samples. The control samples include cells that have not been treated.